studi
describ
antibodydepend
nk
cell
degranul
assay
biomark
assess
antibodydepend
cellular
cytotox
adcc
respons
influenza
plasma
antibodi
therapi
influenza
infect
concentr
neutral
antibodi
nab
hemagglutinin
receptor
influenza
virus
current
determin
protect
infect
particularli
follow
receipt
season
influenza
vaccin
howev
limit
assess
protect
nab
titer
incur
full
protect
vari
ii
nab
titer
account
entir
breadth
antibodi
respons
viral
infect
previou
report
indic
antibodi
prime
adcc
play
vital
role
control
influenza
infect
thu
quantifi
assess
protect
influenza
report
demonstr
nonradioact
assay
assess
nk
cell
activ
marker
adcc
nk
cell
interact
opson
viral
antigen
express
surfac
infect
raji
target
cell
result
effector
cell
degranul
surrog
express
posit
correl
determin
hai
titer
sustain
nk
cell
activ
although
nk
cell
activ
seen
plasma
sampl
hai
titer
vari
amongst
sampl
high
hai
titer
furthermor
sustain
nk
cell
degranul
determin
influenzavaccin
transchromosom
bovin
intraven
immunoglobulin
indic
potenti
util
therapi
influenza
treatment
conclud
assay
reproduc
relev
influenza
signific
caus
morbiditymort
human
popul
across
globe
lavanchi
influenza
virus
estim
caus
million
sever
clinic
infect
yearli
result
fatal
stohr
influenza
virus
includ
subtyp
involv
season
epidem
pandem
potenti
stohr
immunemedi
protect
influenza
virus
thought
larg
depend
neutral
antibodi
nab
specif
membranedist
portion
viral
envelop
protein
hemagglutinin
ha
prevent
bind
viru
target
cell
sialic
acid
matlin
et
al
assess
antibodi
ab
respons
specif
influenza
subtyp
import
diagnost
epidemiolog
immunolog
tool
cauchemez
et
al
demonstr
serotypeand
subserotyp
subtyp
specif
ab
respons
individu
follow
suspect
infect
vaccin
may
accomplish
varieti
method
influenza
wide
use
assay
assess
antibodi
igg
otherwis
level
hemagglutin
inhibit
hai
assay
provid
rel
measur
quantiti
antiha
ab
present
patient
seraplasma
hobson
et
al
katz
et
al
addit
assay
employ
includ
neuraminidas
inhibit
ni
microneutr
mn
assay
use
detect
neuraminidasespecif
antibodi
abil
plasma
antibodi
neutral
infect
influenza
viru
respect
serolog
method
describ
assess
entir
breadth
antibodi
mediat
respons
influenza
virus
addit
serolog
cellular
effector
function
includ
complement
activ
terajima
et
al
ii
phagocytosi
el
bakkouri
et
al
huber
et
al
anasosabatiz
et
al
iii
antibodydepend
cellular
cytotox
adcc
greenberg
et
al
jegaskanda
et
al
jegaskanda
et
al
jegaskanda
et
al
jegaskanda
et
al
b
vanderven
et
al
zhong
et
al
co
et
al
florek
et
al
jegaskanda
et
al
srivastava
et
al
jegaskanda
et
al
jegaskanda
et
al
antiinfluenza
nab
directli
combin
complement
block
deactiv
infecti
viral
particl
prior
entri
host
cell
howev
viral
particl
escap
nab
establish
infect
insid
target
cell
nab
may
longer
optim
effect
immun
effector
cell
requir
recogn
elimin
viral
infect
cell
nk
cell
immun
effector
cell
type
provid
first
line
defens
infect
cell
malign
nk
cell
bind
cell
surfac
antigenab
immun
complex
via
fc
portion
antibodi
receptor
found
number
differ
effector
cell
importantli
nk
cell
involv
effector
cell
recognit
viral
infect
cell
induct
adcc
wren
et
al
express
nk
cell
use
surrog
marker
identif
natur
killer
cell
activ
alter
et
al
adcc
influenza
demonstr
number
studi
greenberg
et
al
jegaskanda
et
al
jegaskanda
et
al
jegaskanda
et
al
jegaskanda
et
al
b
vanderven
et
al
zhong
et
al
co
et
al
florek
et
al
jegaskanda
et
al
srivastava
et
al
jegaskanda
et
al
jegaskanda
et
al
dilillo
et
al
cox
et
al
assay
base
radioact
chromiumlabel
target
cell
use
demonstr
presenc
antibodi
capabl
adcc
activ
greenberg
et
al
demonstr
presenc
adcc
antibodi
clinic
influenza
serum
sampl
co
et
al
assay
base
assess
express
nk
cell
follow
incub
serumtr
plate
coat
influenza
protein
conduct
jegaskanda
et
al
jegaskanda
et
al
jegaskanda
et
al
b
vanderven
et
al
zhong
et
al
florek
et
al
jegaskanda
et
al
jegaskanda
et
al
jegaskanda
et
al
studi
larg
use
flowbas
adcc
nk
cell
activ
assay
use
method
less
physiolog
relev
due
remov
target
cell
effector
cell
interact
one
influenza
adcc
studi
util
flowbas
method
assess
target
cell
lysi
via
membranelabel
dye
follow
effector
cell
interact
srivastava
et
al
influenzainfect
immort
human
epitheli
cell
line
also
util
measur
adcc
ab
activ
use
express
nk
cell
coincub
target
cell
jegaskanda
et
al
jegaskanda
et
al
dilillo
et
al
addit
bioassay
measur
activ
adccab
also
conduct
use
influenza
hatransfect
cell
follow
incub
human
plasma
sampl
jurkat
effector
cell
cox
et
al
addit
nonradioact
adcc
assay
becom
commerci
avail
surowi
et
al
adccmedi
clearanc
viral
infectect
cell
adcc
protect
follow
vaccin
natur
infect
potenti
import
immun
mechan
influenza
infect
immunoglobulinbas
therapuet
product
human
intraven
immunoglobulin
ivig
also
capabl
stimul
adcc
immun
respons
maxim
effect
therapeut
previou
studi
demonstr
capac
immun
bovin
igg
induc
nk
cell
activ
mediat
adcc
immun
hiv
infect
kramski
et
al
recent
sab
biotherapeut
develop
transchromosom
tc
bovin
system
replac
knock
bovin
immunoglobulin
gene
human
artifici
choromosom
contain
full
germlin
sequenc
human
immunoglobulin
kuroiwa
et
al
matsushita
et
al
matsushita
et
al
sano
et
al
tc
bovin
capabl
produc
full
human
antibodi
use
produc
polyclon
human
igg
hantaviru
hooper
et
al
middl
east
respiratori
syndromerel
coronaviru
merscov
ebola
zair
viru
dye
et
al
tc
bovin
hyperimmun
pandem
strain
influenza
also
potenti
produc
commerci
viabl
ivig
product
capabl
neutral
antibodi
adccantibodi
function
develop
standard
nk
cell
assay
detect
adcc
activ
influenza
virus
could
aid
assess
popul
immun
ii
vaccin
therapuet
ivig
treatment
efficaci
iii
possibl
clinic
assay
indic
infect
individu
progress
sever
ill
examin
adccab
plasma
panel
collect
includ
tc
bovin
ivig
util
highthroughput
nonradioact
assay
assess
influenza
infect
raji
target
cell
plasma
ab
abil
activ
nk
effector
cell
demonstr
degranul
surrog
express
studi
describ
reproduc
relev
method
assess
nk
cell
degranul
titer
plasma
sera
sampl
use
assay
determin
tc
bovin
ivig
high
titer
nk
cell
degranul
antibodi
thu
repres
system
could
use
countermeasur
rapidli
produc
fulli
human
antibodi
capabl
elicit
adcc
respons
pandem
influenza
raji
cell
american
type
cultur
collect
atcc
manassa
va
grown
complet
rpmi
media
gibco
langley
ok
fetal
bovin
serum
fb
qualiti
biolog
gaithersburg
md
penicillinstreptomycin
ps
corn
corn
ny
prior
infect
influenza
cell
wash
x
pb
resuspend
rpmi
media
bovin
serum
albumin
bsa
fisher
scientif
pittsburgh
pa
ps
tosyl
phenylalanyl
chloromethyl
keton
tpck
accur
chemic
westburi
ny
tpckml
media
blood
collect
healthi
donor
protocol
approv
naval
medic
research
center
institut
review
board
complianc
applic
feder
regul
govern
protect
human
subject
hrpp
effector
cell
assess
nk
cell
degranul
nonadher
fraction
peripher
blood
mononuclear
cell
pbmc
healthi
donor
donor
pbmc
screen
nk
cell
degranul
capac
lab
previous
publish
sun
et
al
util
data
studi
donor
pbmc
degranul
capac
background
util
subsequ
experi
describ
within
manuscript
prepar
nonadher
pbmc
describ
previous
sun
et
al
briefli
cryopreserv
whole
pbmc
thaw
wash
brought
cellsml
cultur
medium
place
well
plate
becton
dickinson
multiwelltm
primariatm
well
becton
dickinson
compani
franklin
lake
nj
mlwell
plate
kept
h
allow
monocyt
adher
plate
adher
nonadher
cell
gentli
collect
plate
tube
nonadher
cell
wash
brought
cellsml
cultur
medium
cell
left
tube
humidifi
co
incub
overnight
ad
effector
target
cell
plasma
wash
count
adjust
ml
cultur
medium
isol
pandem
strain
influenza
reagent
resourc
manassa
va
viru
amplifi
fertil
chicken
egg
charl
river
laboratori
wilmington
egg
incub
humid
co
h
transfer
addit
h
allanto
fluid
collect
spun
remov
debri
titer
turkey
red
blood
cell
lampir
biolog
laboratori
pipersvil
pa
determin
hemagglutin
unit
hau
determin
infect
rate
raji
cell
determin
incub
cellswel
well
cell
culturetr
plate
corn
costar
corn
ny
dilut
viru
repres
hau
per
well
h
rpmi
media
bsa
tpck
supplement
tpck
base
previou
usag
influenza
infect
studi
jegaskanda
et
al
su
et
al
cell
wash
two
time
x
pb
half
use
determin
cell
surfac
express
ha
half
intracellular
express
ha
assess
cell
surfac
stain
antiha
monoclon
antibodi
millipor
billerica
appli
dilut
min
room
temperatur
assess
intracellular
express
cell
fix
permeabil
bd
cytofixcytoperm
bd
bioscienc
san
jose
ca
min
room
temperatur
wash
two
time
permwash
prior
receiv
antibodi
cell
wash
stain
secondari
fitcconjug
goat
antibodi
bd
pharmingen
san
jose
ca
dilut
min
dark
cell
wash
resuspend
x
pb
assess
flow
cytometri
becton
dickinson
fac
canto
ii
san
jose
ca
cell
assess
mean
fluoresc
intens
mfi
ha
express
cell
human
plasma
sampl
obtain
nation
institut
allergi
infecti
diseas
protocol
approv
naval
medic
research
center
institut
review
board
complianc
applic
feder
regul
govern
protect
human
subject
hrpp
plasma
sampl
screen
level
antibodi
acalifornia
ha
receptor
use
world
health
organizationcent
diseas
control
prevent
hai
assay
previous
describ
defang
et
al
nk
cell
degranul
assay
nk
cell
degranul
assess
express
effector
cell
use
modifi
method
describ
previous
sun
et
al
chung
et
al
briefli
well
ubottom
tissu
culturetr
plate
corn
costar
raji
cell
aliquot
cellswel
wash
two
time
pb
remov
residu
fb
viru
stock
dilut
final
concentr
hau
per
well
rpmi
media
bsa
ps
tpck
aliquot
plate
incub
h
humid
co
plate
wash
two
time
pb
dilut
plasma
appli
incub
ice
h
plate
wash
two
time
pb
target
cell
treat
plasma
divid
two
part
one
assess
opson
immedi
plasma
treatment
determin
nk
cell
degranul
opson
plate
peconjug
igg
fc
gammaspecif
ebiosci
san
diego
ca
dilut
ad
plate
incub
room
temperatur
min
dark
plate
wash
antibodi
opson
infect
cell
assess
via
flow
cytometri
fac
canto
ii
becton
dickinson
set
nk
cell
degranul
assay
effector
cell
collect
count
reconstitut
complet
rpmi
media
concentr
cellsml
well
effector
cell
ad
plasmatr
infect
uninfect
target
cell
raji
ratio
incub
h
media
remov
antibodi
cocktail
contain
apc
percp
pe
fitc
bd
bioscienc
ad
well
incub
dark
room
temperatur
min
cell
wash
twice
pb
resuspend
pb
cell
assess
flow
cytometri
nk
cell
gate
percentag
cell
within
nk
cell
popul
analyz
effector
cell
cultur
target
cell
set
neg
control
background
express
effector
cell
cultur
plasmauntr
target
cell
set
baselin
control
abindepend
nk
cell
activ
statist
perform
use
graphpad
prism
softwar
graphpad
la
jolla
ca
determin
could
infect
raji
target
cell
assay
infect
raji
cell
dilut
stock
viru
repres
hau
incub
cell
h
assess
cell
viral
antigen
express
mab
result
indic
rate
infect
fig
congruent
previou
determin
srivastava
et
al
cell
popul
either
stain
right
incub
fix
permeabil
compar
overal
ha
express
vs
ha
express
cell
surfac
fig
indic
ha
express
h
follow
viru
incub
cell
howev
taper
nonpermeabil
popul
increas
dilut
viru
fig
contrast
permeabil
popul
demonstr
consist
rate
ha
express
dilut
believ
taper
ha
express
seen
nonpermeabil
cell
like
due
increas
nonintern
virion
present
cell
surfac
lower
dilut
viru
compar
higher
dilut
result
higher
cell
surfac
stain
ha
lower
dilut
viru
compar
higher
dilut
without
affect
overal
intracellular
level
ha
addit
mean
fluoresc
intens
ha
express
significantli
higher
permeabil
cell
nonpermeabil
cell
dilut
viru
fig
next
elucid
opson
antigen
express
surfac
infect
target
cell
opson
would
activ
nk
effector
cell
assess
across
four
dilut
plasma
four
dilut
viru
infect
select
two
plasma
sampl
high
hai
titer
hai
hai
gate
strategi
assay
shown
fig
nk
cell
could
distinguish
nkt
cell
costain
nk
cell
visual
concomit
loss
nk
cell
activ
determin
enhanc
express
assess
opson
target
cell
incub
human
plasma
obtain
volunt
donor
demonstr
low
opson
assess
mfi
antigen
ag
ab
bind
plasma
viral
dilut
fig
contrast
cell
treat
demonstr
high
opson
greater
mfi
remain
dilut
plasma
hau
dilut
viru
fig
opson
decreas
dilut
plasma
assess
opson
would
result
nk
cell
activ
incub
effector
cell
target
h
stain
cell
select
nk
cell
popul
determin
nk
cell
activ
probe
express
consist
opson
data
signific
express
cell
incub
contrast
cell
incub
express
rise
baselin
level
fig
taken
togeth
data
suggest
nk
cell
activ
interact
opson
antigen
express
surfac
infect
cell
remain
experi
standard
infect
target
cell
hau
per
cell
select
one
plasma
sampl
hai
test
opson
fig
nk
cell
degranul
fig
reproduc
three
experi
infect
uninfect
target
cell
titer
ab
capabl
stimul
nk
cell
activ
assess
determin
fold
increas
nk
cell
respons
fig
absolut
valu
nk
cell
respons
fig
fold
increas
nk
cell
respons
determin
fold
increas
nk
cell
respons
infect
cell
compar
uninfect
cell
dilut
absolut
valu
nk
cell
respons
determin
percentag
nk
cell
express
infect
cell
minu
percentag
uninfect
cell
highest
dilut
plasma
twofold
increas
express
absolut
valu
one
determin
titer
nk
cell
degranul
select
sampl
human
plasma
hai
titer
rang
organ
low
hai
middl
hai
high
hai
group
tabl
opson
present
bind
intens
uninfect
cell
consist
low
infect
cell
observ
mfi
higher
opson
antigen
dilut
plasma
except
fig
higher
dilut
opson
taper
dramat
cell
treat
low
titer
middl
titer
plasma
phenomenon
occur
lesser
extent
middl
titer
group
observ
higher
opson
dilut
sampl
high
titer
group
continu
see
signific
opson
higher
dilut
except
plasma
consist
show
diminish
opson
akin
sampl
low
titer
fig
order
assess
nk
cell
degranul
incub
target
cell
condit
follow
incub
effector
cell
two
hour
nk
cell
activ
determin
percentag
nk
cell
express
fig
two
ten
sampl
low
titer
group
nk
cell
express
dilut
reduc
around
baselin
level
subsequ
dilut
five
eight
middl
titer
plasma
sampl
least
nk
cell
express
dilut
nk
cell
degranul
vari
particularli
wide
among
high
titer
sampl
three
eight
high
titer
human
plasma
sampl
least
nk
cell
express
dilut
continu
observ
high
express
higher
dilut
sampl
hai
demonstr
low
opson
low
nk
cell
degranul
normal
data
nk
cell
activ
also
present
fold
increas
absolut
valu
infect
cell
compar
uninfect
cell
heat
map
analysi
fig
express
fold
increas
infect
cell
compar
uninfect
cell
demonstr
trend
toward
sustain
greater
twofold
fold
increas
tabl
human
plasma
sampl
set
transchromosom
tc
bovin
ivig
nk
cell
titer
assess
highest
plasma
dilut
absolut
valu
express
nk
cell
greater
one
foldchang
express
nk
cell
greater
two
compar
uninfect
cell
hemagglutin
inhibit
hai
higher
dilut
high
hai
titer
plasma
compar
low
middl
titer
sampl
dilut
plasma
nk
cell
degranul
assay
demonstr
posit
correl
r
absolut
valu
respons
fold
increas
respons
fig
serum
dilut
correl
absolut
valu
fold
increas
r
indic
relationship
two
valu
util
determin
nk
cell
titer
mfi
agab
bindingopson
target
cell
also
posit
correl
fold
increas
respons
dilut
plasma
fig
indic
import
agab
bind
elicit
nk
cell
degranul
use
tc
bovin
ivig
sampl
hai
determin
opson
infect
uninfect
raji
cell
assay
fig
nk
cell
express
infect
uninfect
target
cell
determin
dilut
ivig
fig
dilut
tc
bovin
ivig
demonstr
nk
cell
degranul
cultur
infect
target
cell
use
inform
nk
cell
degranul
titer
tc
bovin
ivig
determin
tabl
titer
ab
capabl
stimul
nk
cell
activ
assess
determin
fold
increas
nk
cell
respons
fig
absolut
valu
nk
cell
respons
fig
use
titer
inform
human
plasma
sampl
set
tc
bovin
ivig
conduct
spearman
correl
analysi
determin
posit
relationship
exist
hai
titer
nk
cell
degranul
titer
fig
taken
togeth
data
suggest
posit
correl
exist
hai
titer
sustain
nk
cell
activ
although
nk
cell
activ
detect
plasma
sampl
hai
titer
particularli
low
plasma
dilut
vari
amongst
sampl
high
hai
titer
report
demonstr
nonradioact
assay
determin
concentr
adcc
nk
cell
activ
antibodi
human
serum
plasma
abil
activ
nk
cell
demonstr
degranul
express
support
titer
ha
hemagglutin
antibodi
posit
correl
nk
cell
activ
sampl
set
athough
nk
activ
vari
wide
amongst
low
middl
high
hai
titer
plasma
sampl
furthermor
report
influenzavaccin
tc
bovin
ivig
determin
sustain
antibodi
titer
capabl
elicit
nk
cell
degranul
titer
hemagglutin
antibodi
globular
head
ha
receptor
influenza
virus
current
correl
protect
influenza
viru
infect
gener
titer
consid
protect
co
et
al
baz
et
al
howev
vari
wide
amongst
individu
children
particular
usual
experienc
less
exposur
tend
requir
higher
titer
around
incur
protect
rate
black
et
al
protect
titer
vari
even
among
individu
similar
age
rang
co
et
al
hai
assay
screen
hemagglutin
inhibit
current
mean
predict
protect
howev
metric
limit
addit
aforement
unpredict
vari
rang
titer
requir
incur
immun
among
individu
hai
assay
determin
level
hemagglutin
ha
globular
head
alon
activ
neutral
nonneutr
antibodi
ha
stalk
viral
protein
ion
channel
matrix
protein
nucleoprotein
neuraminidas
detect
assay
routin
evalu
vaccineinduc
antibodi
respons
determin
protect
titer
potenti
benefit
util
addit
influenza
assay
ni
mn
adcc
assay
mn
assay
instanc
demonstr
util
evalu
influenza
serostatu
individu
evalu
protect
titer
season
influenza
verschoor
et
al
importantli
immun
respons
adcc
establish
vital
provid
protect
influenza
virus
greenberg
et
al
jegaskanda
et
al
jegaskanda
et
al
jegaskanda
et
al
jegaskanda
et
al
b
co
et
al
jegaskanda
et
al
srivastava
et
al
dilillo
et
al
simhadri
et
al
demonstr
nk
cell
degranul
assay
metric
adcc
activ
util
influenzainfect
raji
cell
target
consist
previou
report
util
raji
cell
target
adcc
activ
found
raji
cell
high
percentag
infect
influenza
srivastava
et
al
shown
raji
cell
infect
express
ha
antigen
high
rate
opson
result
compar
infect
uninfect
util
raji
cell
instead
cell
previous
use
influenza
adcc
assay
nonadher
conveni
highthroughput
flowbas
assay
commerci
avail
nonradioact
adcc
report
assay
recent
develop
promega
adcc
report
bioassay
core
kit
surowi
et
al
util
jurkat
effector
cell
raji
target
cell
demonstr
util
raji
cell
adcc
assay
assay
describ
report
relev
explor
nk
cell
degranul
express
result
bind
opson
antigen
surfac
infect
target
cell
previous
nk
cell
activityadcc
activ
detect
use
cr
label
greenberg
et
al
co
et
al
seraplasmatr
elisa
plate
coat
purifi
viral
protein
jegaskanda
et
al
jegaskanda
et
al
jegaskanda
et
al
b
vanderven
et
al
zhong
et
al
florek
et
al
jegaskanda
et
al
includ
use
dimerbind
assay
wine
et
al
major
advantag
method
describ
herein
cr
label
includ
remov
radioact
materi
increas
fig
correl
hai
titer
nk
cell
degranul
titer
human
plasma
set
transchromosom
bovin
ivig
therapeut
nk
cell
titer
assess
highest
plasma
dilut
absolut
valu
express
nk
cell
greater
one
foldchang
express
nk
cell
compar
uninfect
cell
greater
two
nk
cell
titer
compar
hemagglutin
inhibit
hai
titer
correl
coeffici
r
equal
p
valu
equal
indic
posit
correl
sampl
plot
sever
sampl
overlap
nk
cell
degranul
titer
set
statist
result
nonparametr
spearman
correl
analysi
twotail
bj
morrison
et
al
journal
virolog
method
sensit
cr
assay
often
demonstr
low
sensit
spontan
releas
isotop
nonlys
target
cell
zaritskaya
et
al
elisabas
approach
lend
well
highthroughput
assay
method
coat
elisa
plate
purifi
antigen
also
remov
radioact
hazard
also
limit
plateco
method
excel
mean
select
specif
antibodi
given
antigen
serum
plasma
howev
remov
effector
cell
interact
opson
antigen
infect
cell
method
return
cell
cell
interact
use
raji
cell
target
addit
compon
plasma
well
cell
surfac
may
affect
bind
affin
fc
region
receptor
effector
cell
variabl
remov
altogeth
antibodi
purifi
andor
present
purifi
antigen
alon
srivastava
et
al
wren
et
al
nk
cell
activ
control
balanc
inhibitori
activ
signal
moretta
et
al
advantag
method
describ
herein
could
allow
futur
studi
deepli
assess
nk
cell
activationinhibit
balanc
set
influenzainfect
target
cell
adcc
use
target
cell
provid
sound
model
assess
process
adcc
prime
context
infect
influenza
furthermor
method
consist
reproduc
demonstr
opson
degranul
effector
cell
fig
futur
studi
need
determin
well
raji
target
cell
assay
describ
herein
correl
elisabas
includ
dimerbind
assay
use
plasma
set
demonstr
posit
correl
nk
cell
degranul
hai
titer
howev
note
correl
conduct
rel
small
set
sampl
relationship
hai
titer
nk
cell
degranul
titer
complic
demonstr
correl
herein
present
set
plasma
higher
hai
titer
tend
demonstr
higher
abil
sustain
nk
cell
activitynk
degranul
titer
howev
nk
cell
activ
observ
plasma
hai
titer
lower
suggest
protect
titer
hai
addit
nk
cell
activ
vari
person
high
hai
titer
endpoint
titer
rang
consist
previous
report
regard
weak
correl
hai
adcc
antibodi
titer
zhong
et
al
co
et
al
addit
observ
multipl
experi
particular
note
hai
hai
vastli
differ
abil
stimul
nk
cell
degranul
despit
higher
hai
titer
poorer
induc
adcc
suggest
hai
titer
strongli
correl
adcc
titer
recent
evid
suggest
haiinduc
antibodi
optim
induc
adcc
activ
leon
et
al
also
report
indic
presenc
crossreact
adccmedi
ab
titer
influenzaseroposit
individu
without
detect
nab
titer
jegaskanda
et
al
jegaskanda
et
al
terajima
et
al
aggreg
report
suggest
hai
surrog
nab
titer
case
correl
adccmedi
ab
titer
haiinduc
antibodi
may
fact
block
induct
adcc
antibodi
correl
determin
hai
titer
nk
cell
degranul
titer
may
attribut
overal
higher
titer
influenzaspecif
antibodi
present
high
hai
sampl
compar
low
hai
sampl
final
observ
mild
correl
agab
bind
intens
surfac
infect
cell
nk
cell
degranul
activ
suggest
serumplasma
without
protect
hai
titer
opson
infect
cell
essenti
sampl
adcc
activ
pandem
influenza
demonstr
mortal
critic
ill
patient
webb
et
al
develop
altern
therapi
addit
vaccin
warrant
prepar
futur
pandem
strain
influenza
influenza
passiv
immunotherapi
treatment
includ
use
convalesc
plasma
hyperimmun
immunoglobulin
monoclon
antibodi
therapi
convalesc
patient
blood
product
demonstr
util
reduc
mortal
associ
spanish
influenza
pandem
luke
et
al
treatment
influenza
zhou
et
al
respons
rapid
need
gener
human
antibodi
passiv
immunotherapi
pandem
strain
influenza
monoclon
antibodi
convalesc
plasma
hyperimmun
humanderiv
immunoglobulin
ideal
due
econom
logist
time
factor
one
potenti
sourc
rapidli
produc
fulli
human
polyclon
antibodi
passiv
immunotherapi
tc
bovin
system
vaccin
tc
bovin
produc
convalesc
plasma
pool
human
igg
purifi
g
tc
human
igg
per
anim
per
month
use
assay
assess
influenzavaccin
tc
bovin
ivig
therapeut
nk
cell
degranul
specif
virallyinfect
cell
demonstr
high
titer
nk
degranul
antibodi
addit
benefit
influenzavaccin
tc
bovin
ivig
therapi
compar
human
ivig
therapeut
bovin
colostrum
igg
therapeut
need
assess
howev
influenzavaccin
tc
bovin
ivig
therapi
deserv
addit
evalu
potenti
therapeut
critic
ill
patient
therapi
abil
initi
adcc
antibodi
respons
import
mechan
protect
alreadi
infect
patient
nk
cell
degranul
assay
describ
relev
global
surveil
influenza
adccmedi
respons
influenza
recogn
broader
rang
influenza
strain
neutral
antibodi
gener
target
highli
variabl
region
influenza
protein
jegaskanda
et
al
adccmedi
antibodi
demonstr
novel
swineorigin
influenza
viru
prior
pandem
individu
greater
year
age
detect
hai
titer
jegaskanda
et
al
furthermor
studi
nab
detect
nonnab
titer
correl
protect
sever
infect
odonnel
et
al
weinfurt
et
al
demonstr
util
assay
assess
adcc
global
influenza
surveil
popul
immun
use
adcc
assay
may
also
drive
shift
away
sole
assess
role
neutral
haimedi
ab
vaccin
efficaci
antibodi
passiv
immunotherapuet
assess
adccmedi
ab
target
intern
protein
influenza
viru
target
adcc
includ
ha
zhong
et
al
ii
intracellular
nucleoprotein
antigen
jegaskanda
et
al
shown
transient
express
viral
infect
cell
surfac
yewdel
et
al
iii
neurominidas
protein
terajima
et
al
vaccin
induct
therapeut
product
antibodi
target
influenza
intern
protein
via
adcc
respons
may
prove
new
develop
influenza
vaccinetreat
design
conclus
adcc
vital
immun
respons
control
influenza
infect
metric
assess
broad
spectrum
influenza
vaccin
influenza
passiv
immunotherapi
approach
adcc
assess
also
vital
tool
conduct
serosurveil
influenza
investig
order
better
assess
breadth
antibodi
respons
epidemicpandem
season
influenza
could
especi
relev
assess
influenza
exposur
protect
immun
repsons
nonlowneutr
patient
plasma
nk
cell
activ
assay
demonstr
report
could
use
futur
research
investig
role
adcc
influenza
possibl
predict
patient
clinic
respons
ii
metric
vaccin
immun
respons
iii
tool
assess
adcc
activ
patient
plasma
global
iv
tool
assess
immunoglobulin
product
tc
bovin
ivig
view
express
articl
author
necessarili
reflect
offici
polici
posit
depart
navi
depart
defens
us
govern
author
militari
servic
member
employe
us
govern
work
prepar
part
offici
duti
titl
usc
provid
copyright
protect
titl
avail
work
unit
state
govern
titl
usc
defin
us
govern
work
work
prepar
militari
servic
member
employe
us
govern
part
person
offici
duti
work
support
work
unit
number
global
emerg
infect
surveil
respons
system
author
declar
conflict
interest
